Goldman SachsGSHOLDMar 01, 2017Stock price when the opinion was issued
As of Jul 21, 2026. Market Open.
Different businesses. LLY is a big play in GLP-1 drugs. How will pills effect the injections business? LLY has done a good job of navigating these new pills. GS enjoys increased stock market and IPO businesses. He prefers LLY, which is tied to a secular growth trend, but GS' good times in capturing revenue in this cycle will end.
Mergers are increasing, and banks like GS makes advisory fees from them. Also, the banks have been rallying since oil slumped, and will benefit further from rising interest rates, which appears will happen later this year. Plus, hyperscalers may need to keep borrowing money to keep competing with each other.
You’re not going to get the same type of upside that it had from $150 to the current price. But they are going to make hay while the sun is shining. If Donald Trump has his way, this could be 3 or 4 pretty good years for US financials. (He has a better idea for a Canadian financial.) (See Top Picks.)